OASIS and PIONEER PLUS Support High-Dose Oral Semaglutide
Higher doses of oral semaglutide (25 mg and 50 mg) seem to be effective in type 2 diabetes and obesity, improving upon results obtained with currently approved maximum dose of oral semaglutide 14 mg daily.
Medscape Medical News
source https://www.medscape.com/viewarticle/993672?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/993672?src=rss
Comments
Post a Comment